News About: Pharm. Industry
‘Zemiglo’ license lawsuit getting serious, battling over ‘marketing information disclosure’
The LG Chem(former LG Life Sciences) and Sanofi Aventis’ ‘Zemiglo License Lawsuit’ is getting serious.
At the last trial on the 20th, the two sides had different opinions over how far Sanofi should reveal its electro...
Drug price negotiation for ‘Tagrisso’ called off once again, brings controversy of special treatment for multinational pharma
The drug price negotiation for AstraZeneca Korea’s ‘Tagrisso,’ a treatment for non-small cell lung cancer with T790M mutations, has been called off once again, which raised controversy about special treatments on the ...
Green Cross to develop high-volume vaccine for elders for first time in Korea
An influenza vaccine which is more effective for elders will be developed.
Green Cross(CEO Eun-Cheol Huh) announced on the 19th that it acquired approval for the Phase I clinical trial plan of a high-volume tetravale...
Which are foreign company stocks most purchased by NPS?
The National Pension Service(NPS) reportedly purchased a large amount of Microsoft(MS) and Toyota stocks this year.
According to the ‘National Pension’s Top 10 Straight Foreign Stock Purchases’ that The Minjoo Party ...
Which will be the first one to establish ‘global standard bribery management system’?
As the Korea Pharmaceutical and Bio-Pharma Manufacturers Association decided to sequentially adopt the ‘ISO37001’ from the chairmen’s companies as a method to strengthen company transparency, pharmaceutical companies ...
Celltrion, “We’re preparing for the U.S. FDA’s onsite inspection for our first global generic”
In response to the Korea Exchange’s request of inquiry notice on the 17th, Celltrion officially announced on the 18th “We carefully reviewed each item on Paragraph 1 of Article 6 of the KOSDAQ’s Posting Regulations an...
Series of administrative measures on multinational pharmas for violating Pharmaceutical Affairs Law
Multinational pharmaceutical companies branching in Korea have frequently received administrative measures, such as sales suspension and advertising suspension, for violating the Pharmaceutical Affairs Law.
According...
Hanmi’s Poziotinib proved innovative efficacy for NSCLC patients
The advanced clinical result of ‘Poziotinib,’ a novel anticancer drug developed by Hanmi Pharm and licensed to Spectrum Pharmaceuticals, was revealed on the 18th at the World Conference on Lung Cancer(WCLC) in Yokoham...
KPBMA gradually introduce ISO 37001 starting with chairmen’s companies
In order to address distrust of the Korean pharmaceutical industry in rebates, they decided to carry out the ISO 37001 certification starting with the association chairmen’s companies.
Moreover, they also decided to ...
Myungmoon Pharm starts to sell ‘Creon’ under co-promotion agreement with Abott Korea
Myungmoon Pharm will sell ‘Creon,’ a Abott Korea’s pancreatic enzyme replacement therapy(PERT).
Myungmoon Pharm(CEO Seok-Min Woo, Chun-Shik Park) and Aboot Korea(CEO Seung-Yoon Lee) recently signed a co-promotion agr...
